Clinical Trial

A Study of MG-K10 in Chronic Spontaneous Urticaria

Name: A Study of MG-K10 in Chronic Spontaneous Urticaria — clinical trial record (NCT07546487)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study is a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial aimed at evaluating the efficacy and safety of MG-K10 humanized monoclonal antibody injection in CSU trial participants with poor control of second-generation H1 antihistamines.

Trial Details

NCT Number	NCT07546487
Lead Sponsor	Shanghai Mabgeek Biotech.Co.Ltd
Conditions	Chronic Spontaneous Urticaria (CSU)
Enrollment	226 participants
Start Date	2026-04-14
Primary Completion	2028-03-31 (estimated)
Study Completion	2028-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-22